Mechanisms of induced resistance to the antitumoral agent ZZW-115 in pancreas ductal adenocarcinoma
Abstract Drug resistance remains a major obstacle in treating pancreatic ductal adenocarcinoma (PDAC). Nuclear protein 1 (NUPR1), a stress-responsive protein implicated in cancer progression and treatment resistance, represents a potential therapeutic target. Our laboratory has developed NUPR1 inhib...
Saved in:
| Main Authors: | Patricia Santofimia-Castaño, Wenjun Lan, Matias Estaras, Yi Xia, Emma Cosialls, Nicolas Fraunhoffer, Ling Peng, Eduardo Chuluyan, Juan Iovanna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-11931-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma
by: Analia Meilerman Abuelafia, et al.
Published: (2025-07-01) -
Understanding the heterogeneity of pancreatic ductal adenocarcinoma
by: Juan Iovanna, et al.
Published: (2025-10-01) -
Evaluation of Overall Survival Predictions In Inoperable Pancreas Ductal Adenocarcinoma
by: Hasan Önner, et al.
Published: (2022-02-01) -
Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas
by: Ozden Oz, et al.
Published: (2023-07-01) -
Pancreatic ductal adenocarcinoma in a patient with pancreas divisum and gastrointestinal duplication cyst: a case report
by: Naoto Takahashi, et al.
Published: (2021-08-01)